Cortney Caudill

Cortney Caudill

Senior Vice President, Chief Operating OfficeratHalozyme Therapeutics· In the 2025 proxy

Pay in FY2025Halozyme Therapeutics stock +40.8% the same year

Cortney Caudill was paid $3.2M in FY2025 (Dec). Halozyme Therapeutics stock rose 40.8% that year.

Pay$100 in the stock at the end of FY24 → $141
Pay is from the Summary Compensation Table of each Halozyme Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Halozyme TherapeuticsPublic company · 1 yr
    • Senior Vice President, Chief Operating Officer2025 – Present · 1 yrStock in role +174%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?